BURNABY, BRITISH COLUMBIA--(Marketwired - Nov. 18, 2014) -


Premier Diagnostic Health Services Inc. ("Premier" or the "Company") (CSE:PDH) announces that it intends to acquire common shares of the parent company of a reinsurance company registered in Bermuda. The purchase price of the common shares is USD$0.50 per common share. Premier intends to acquire up to USD$1.505M worth of shares, and intends to hold the shares for investment purposes only. The purchase price would be paid in cash.

The reinsurance company underwrites various reinsurance transactions and collateralizes its obligations through the issuance of insurance-linked securities ("ILSs"). The ILSs are offered to third party investors, and the capital from the sale of the ILSs is used to fund the reinsurance business.

About Premier Diagnostic Health Services Inc.

Premier is a Canadian company that provides, through its subsidiaries, advanced medical diagnostic tools using PET/CT technology and/or MRI technology and related diagnostic skills in Canada and in the People's Republic of China, in partnership with local medical professionals, public and private investors, hospitals and clinics. The Company's mission is to provide physicians and other health care professionals with exceptional diagnostic information that will assist them in making medical decisions that lead to better outcomes for their patients. The Company's approach involves building long-term relationships regarding management, quality, and financial services that are necessary to build, operate and grow the diagnostic capacity and capability of hospitals and clinics worldwide.

On behalf of the Board of Directors

Sanjeev Parsad

President, CEO and Director

The Canadian Securities Exchange (CSE) has not reviewed the adequacy or the accuracy of the contents of this document. Company information can be viewed here: www.cnsx.ca. Further information regarding the Company can be found on SEDAR at www.sedar.com.

Legal Notice Regarding Forward Looking Statements: This news release contains "forward-looking statements" within the meaning of applicable Canadian securities legislation. Forward-looking statements are indicated expectations or intentions. Forward-looking statements in this news release include that Premier will complete the share purchase, that the purchase price will be USD$0.50 per common share, that the shares will be acquired by Premier for investment purposes, that Premier will pay the purchase price in cash and that the reinsurance company will operate its business as described. Factors that could cause actual results to be materially different include but are not limited to the following: that the nature of Premier's investment will change, that the purchaser price may change, that the reason for the purchase may change or that the reinsurance company will operate its business differently that described. Investors are cautioned against placing undue reliance on forward-looking statements. It is not our policy to update forward looking statements.

Contact Information:

Premier Diagnostic Health Services Inc.
Sanjeev Parsad
President and CEO
Phone: (604) 678.9115 or Cell: (604) 612.3965
(604) 678.9279 (FAX)